LSDI | Lucy Scientific Discovery Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.4801 - 0.6700
52 Week Range	0.4400 - 12.80
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	306,785
Average Volume	1,226,896
Shares Outstanding	1,764,760
Market Cap	906,910
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2023-02-09

Valuation
Profitability
Growth
Health
P/E Ratio	-0.07
Forward P/E Ratio	N/A
EPS	-7.64
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	2
Country	Canada
Website	LSDI

Lucy Scientific Discovery Inc. researches, develops, manufactures, and commercializes psychedelic products. It offers biological raw materials, crude extracts, psychotropic compounds, and active pharmaceutical ingredients (APIs). Lucy Scientific Discovery Inc. was formerly known as Hollyweed North Cannabis, Inc. The company was incorporated in 2017 and is based in Victoria, Canada.

LSDI's peers: AKAN, ALIM, AQST, BFRI, BHC, CPHI, CPIX, CYTH, DERM, DRRX, COSM, ZOM, HUGE, KALA, KMDA, ORGO, PTPI, RMTI, SCYX, SIGA, SXTC, TEVA, BGXX, ALVO, SHPH, LFCR

*Chart delayed

Analyzing fundamentals for LSDI we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see LSDI Fundamentals page.

Watching at LSDI technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, but short-term trend is bullish. More technicals details can be found on LSDI Technicals page.